5301 - 5310 of 8620 Results
Title
Year
-
RESTRICTEDTitle: The emerging role of SMPD1 mutations in Parkinson's disease: Implications for future studiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 21Issue #: 10Start Page: 1294End Page: 1295Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.08.018Citation Count: 40
- Application of the Movement Disorder Society prodromal criteria in healthy G2019S‐LRRK2 carriers2018OPENTitle: Application of the Movement Disorder Society prodromal criteria in healthy G2019S‐LRRK2 carriersJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 6Start Page: 966End Page: 973Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27342Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6105406Citation Count: 50
-
OPENTitle: α‐synuclein genetic variability: A biomarker for dementia in Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 79Issue #: 6Start Page: 991End Page: 999Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.24664Best OA location URL: http://hdl.handle.net/10044/1/61098Citation Count: 93
-
OPENTitle: Neuronal BAG3 attenuates tau hyperphosphorylation, synaptic dysfunction, and cognitive deficits induced by traumatic brain injury via the regulation of autophagy-lysosome pathwayJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 148Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-024-02810-1Best OA location URL: https://doi.org/10.1007/s00401-024-02810-1Citation Count: 3
- Renin-angiotensin system blockers affect cognitive decline in Parkinson's disease: The PPMI dataset2022RESTRICTEDTitle: Renin-angiotensin system blockers affect cognitive decline in Parkinson's disease: The PPMI datasetJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 105Issue #:Start Page: 90End Page: 95Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.019Citation Count: 13
-
OPENTitle: Reconstitution of cargo-induced LC3 lipidation in mammalian selective autophagyJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 7Issue #: 17Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-byDOI - Digital Object Identifier: 10.1126/sciadv.abg4922Best OA location URL: https://doi.org/10.1126/sciadv.abg4922Citation Count: 43
-
OPENTitle: Mitochondrial DNA deletions in the cerebrospinal fluid of patients with idiopathic REM sleep behaviour disorderJournal Name: eBioMedicinePublisher: Elsevier BVVol: 102Issue #:Start Page: 105065End Page: 105065Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.ebiom.2024.105065Best OA location URL: http://www.thelancet.com/article/S2352396424001002/pdfCitation Count: 6
-
OPENTitle: Early-stage idiopathic Parkinson’s disease is associated with reduced circular RNA expressionJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00636-yBest OA location URL: https://www.nature.com/articles/s41531-024-00636-y.pdfCitation Count: 12
- DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriers2017OPENTitle: DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriersJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 4Start Page: e0175424End Page: e0175424Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0175424Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0175424&type=printableCitation Count: 33
-
OPENTitle: Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 UpdateJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 13Issue #: 4Start Page: 427End Page: 439Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-239901Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd239901?id=journal-of-parkinsons-disease%2Fjpd239901Citation Count: 62